Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Molecular Liquids"
DOI: 10.1016/j.molliq.2021.116655
Abstract: Abstract Corneal neovascularization and other angiogenic disorders are characterized by dysregulation of vascular endothelial growth factor (VEGF). Anti-VEGF therapy, particularly by applying the specific monoclonal antibody Bevacizumab is a widely-used treatment. Chitosan polymer nanoparticles are…
read more here.
Keywords:
interactions bevacizumab;
bevacizumab;
chitosan polymer;
study ... See more keywords